- $5.52bn
- $6.47bn
- $1.33bn
Haemonetics Corp expected to post earnings of 89 cents a share - Earnings Preview
Brief: Haemonetics Receives FDA Clearance For New Teg® 6S Global Hemostasis - HN Cartridge
Brief: Haemonetics Corporation Completes Acquisition Of Attune Medical
U.S. STOCKS ON THE MOVE-Nasdaq, Albemarle, Haemonetics
Haemonetics rises on deal to acquire medical device maker Attune Medical
Brief: Haemonetics Announces Definitive Agreement To Acquire Attune Medical
Haemonetics Corp reports results for the quarter ended in December - Earnings Summary
Brief: Haemonetics - Recorded Amortization Of Acquired Intangible Assets Of $6.9 Million In Q3
Haemonetics Corp expected to post earnings of 94 cents a share - Earnings Preview
Brief: Haemonetics Corporation Completes Acquisition Of Opsens
Haemonetics Corp reports results for the quarter ended in September - Earnings Summary
Haemonetics Corp expected to post earnings of 89 cents a share - Earnings Preview
Press Digest: Canada - Oct 11
Haemonetics rises after all-cash deal to acquire OpSens
Brief: Opsens Signs Definitive Agreement For Its Acquisition By Haemonetics
Brief: Haemonetics Corporation Announces Definitive Agreement To Acquire Opsens
Brief: Haemonetics Announces European Expansion For Vascade Vascular Closure System
Haemonetics gains on annual profit forecast raise
Haemonetics Corp reports results for the quarter ended in June - Earnings Summary